- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session | 3 | capitalmarket.com | ||
| 06.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 06.07. | Glenmark Pharma gains as US arm launches generic Olanzapine injection | 2 | capitalmarket.com | ||
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com | ||
| 11.06. | Cosmo Pharmaceuticals N.V.: Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark | 630 | Newsfile | Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned... ► Artikel lesen | |
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 10.06. | Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom | 3 | capitalmarket.com | ||
| 05.06. | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com | ||
| 30.05. | Glenmark Pharma posts robust Q4 performance | 3 | capitalmarket.com | ||
| 20.05. | IGI, Inc.: Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors | 411 | GlobeNewswire (Europe) | Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells
IGI's clinically validated BEAT platform enabled... ► Artikel lesen | |
| 18.05. | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal | ||
| 12.05. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 2 | capitalmarket.com | ||
| 23.04. | Glenmark Pharmaceuticals Ltd spurts 3.28% | 2 | capitalmarket.com | ||
| 09.04. | Glenmark Gets FDA Approval for Bioequivalent Progesterone Vaginal Insert | 6 | Contract Pharma | ||
| 09.04. | Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg | 942 | PR Newswire | ELMWOOD PARK, N.J., April 9, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration... ► Artikel lesen | |
| 09.04. | Glenmark Pharma gets USFDA nod for Progesterone Vaginal Inserts | 5 | capitalmarket.com | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | 5 | FiercePharma |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,984 | +1,64 % | Daiwa Downgrades SINOPHARM to Hold, Cuts TP to HKD18 | ||
| CSPC PHARMA | 0,968 | +2,59 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) AND ANBENITAMAB (KN026) GRANTED BREAKTHROUGH THERAPY DESIGNATION ... | ||
| WUXI BIOLOGICS | 4,350 | -1,02 % | WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy | SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO)... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,860 | +1,81 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY | ||
| GEDEON RICHTER | 33,300 | +0,06 % | Gedeon Richter Plc.: Interest payment / Principal repayment | ||
| DR REDDYS | 11,300 | -1,74 % | Dr Reddys Laboratories Ltd slips for fifth straight session | ||
| ASPEN PHARMACARE | 7,800 | -0,64 % | ASPEN PHARMACARE HOLDINGS LIMITED - Proposed Succession and Board Composition Update | ||
| SHANGHAI PHARMACEUTICALS | 1,270 | -4,51 % | Dividendenbekanntmachungen (15.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5516 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1102 CAD 0,0686 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| LUYE PHARMA | 0,242 | -0,82 % | LUYE PHARMA Completes Early Redemption of USD180 million Convertible Bonds Due 2028 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,100 | -2,91 % | Dividendenbekanntmachungen (30.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABACUS GROUP UTS AU0000291882 0,0212 AUD 0,0128 EUR ACADIA REALTY TRUST US0042391096 0,2 USD 0,175 EUR ACADIAN TIMBER CORP CA0042721005 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 3,649 | +1,53 % | Hansoh Pharma: Phase III Trial For Ris-Rez Meets Primary Endpoint In China | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its phase III trial evaluating risvutatug rezetecan or Ris-Rez in patients... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,505 | -1,94 % | CHINARES PHARMA (03320): INSIDE INFORMATION POTENTIAL ACQUISITION OF INTEREST IN LIER CHEMICAL | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,910 | +0,55 % | SHINEWAY PHARM (02877): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2026 | ||
| KALBE FARMA | 0,036 | +4,35 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| BAYER | 47,240 | -0,99 % | Glyphosat-Prozess startet: Bayer: Neigt sich der Glyphosat-Spuk seinem Ende zu? | © Foto: KI-generiert mit DALL-EBayer hätte die Glyphosat-Kuh lieber gestern als heute vom Eis. Die Leverkusener wollen gleich 4.000 Klagen in einem Bundesverfahren kippen. Die Hoffnung wächst, aber... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.